New shorter treatment regimen found to be safer, more effective at treating drug-resistant TB
A new all-oral six-month treatment regimen is safer and more effective at treating rifampicin-resistant tuberculosis
tuberculosis
Ending tuberculosis is a race against time and drug resistance
The tuberculosis (TB) burden in the WHO European Region as a whole is decreasing, and
Quarter of global population at tuberculosis risk: Study
Tuberculosis, which is caused by a bacterium called Mycobacterium Tuberculosis, affects more than 10 million
Scientists developing new vaccine strategy for tuberculosis: Experimental TB protection delivered through a spray instead of a shot
For years, scientists have been trying to come up with a better way to protect
Cocktail of common antibiotics can fight resistant E. coli
A group of scientists in Denmark is trying to get one step ahead in the
South Asians at risk for tuberculosis often are not tested
Many South Asian immigrants from countries where tuberculosis (TB) is common do not get tested